Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
AQST Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
31.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
141.90%
AQST Stock Analysis
AQST
PE Ratio:
AQST
PEG Ratio:
Not Available
AQST
Forward EPS Growth (12 month):
0.00%
AQST
PS Ratio:
8
AQST
PSG Ratio:
0.2
AQST
Forward Revenue Growth (12 month):
39.30%
AQST Articles
No data was found